These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acellular pertussis vaccines: new preparation. Better tolerated but less active? Prescrire Int; 2000 Feb; 9(45):204-7. PubMed ID: 11503797 [TBL] [Abstract][Full Text] [Related]
3. Combined acellular pertussis vaccines: new indication. No tangible benefit in primary vaccination. Prescrire Int; 2002 Jun; 11(59):73-5. PubMed ID: 12068840 [TBL] [Abstract][Full Text] [Related]
4. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
5. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705 [TBL] [Abstract][Full Text] [Related]
6. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780 [TBL] [Abstract][Full Text] [Related]
8. Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. Noble GR; Bernier RH; Esber EC; Hardegree MC; Hinman AR; Klein D; Saah AJ JAMA; 1987 Mar; 257(10):1351-6. PubMed ID: 3820444 [TBL] [Abstract][Full Text] [Related]
9. Whooping cough, twenty years from acellular vaccines introduction. Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141 [TBL] [Abstract][Full Text] [Related]
11. The acellular pertussis vaccine trials: an interpretation. Plotkin SA; Cadoz M Pediatr Infect Dis J; 1997 May; 16(5):508-17; discussion 517-9. PubMed ID: 9154547 [No Abstract] [Full Text] [Related]
12. [Efficacy of acellular pertussis vaccines]. Wirsing von König CH; Finger H Immun Infekt; 1995 Aug; 23(4):125-9. PubMed ID: 7558115 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization. Kuno-Sakai H; Kimura M Pediatr Int; 2004 Dec; 46(6):650-5. PubMed ID: 15660862 [TBL] [Abstract][Full Text] [Related]
14. Immune responses to pertussis vaccines and disease. Edwards KM; Berbers GA J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958 [TBL] [Abstract][Full Text] [Related]
15. The effectiveness of whole-cell pertussis vaccines. Plotkin SA Dev Biol Stand; 1997; 89():171-4. PubMed ID: 9272348 [TBL] [Abstract][Full Text] [Related]
18. Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection. Herzog C Expert Rev Vaccines; 2015; 14(8):1065-72. PubMed ID: 26098640 [TBL] [Abstract][Full Text] [Related]
19. Cellular and acellular pertussis vaccines in adults. Keitel WA Clin Infect Dis; 1999 Jun; 28 Suppl 2():S118-23. PubMed ID: 10447029 [TBL] [Abstract][Full Text] [Related]
20. An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines. Geier DA; Geier MR Brain Dev; 2004 Aug; 26(5):296-300. PubMed ID: 15165669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]